ישראל -
עברית -
Ministry of Health
אמולסידרם
trupharm marketing 1985 ltd. - benzalkonium chloride 0.5 %w/v; isopropyl myristate 25 %w/v - emulsion - benzalkonium - for the treatment of dry skin conditions especially associated with eczema, ichtyosis or xeroderma. it permits rehydratation of the keratin.
ישראל -
עברית -
Ministry of Health
טייגר באלם לבן
rafa laboratories ltd - cajuput oil; camphor; clove oil; dementholised mint oil; menthol - משחה - camphor 11 %w/w; menthol 8 %w/w; cajuput oil 13 %w/w; clove oil 1.5 %w/w; dementholised mint oil 16 %w/w - various - for the temporary relief of muscular aches and pains.
ישראל -
עברית -
Ministry of Health
טייגר באלם אדום
rafa laboratories ltd - cajuput oil; camphor; clove oil; dementholised mint oil; menthol - משחה - camphor 11 %w/w; menthol 10 %w/w; cajuput oil 7 %w/w; dementholised mint oil 6 %w/w; clove oil 5 %w/w
ישראל -
עברית -
Ministry of Health
חמאת גוף - daje vu passion's touch
א.ל. ארמן יצור תמרוקים בעמ - לחות לעור
ישראל -
עברית -
Ministry of Health
נורקורון 4 מ"ג
merck sharp & dohme israel ltd - vecuronium bromide 4 mg/ml - powder for solution for injection - vecuronium - ajunct to general anaesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery.
ישראל -
עברית -
Ministry of Health
איבומק וטרינרי
beit-erez havat milatin ltd - ivermectin - תמיסה להזרקה - ivermectin 10 mg/ml
ישראל -
עברית -
Ministry of Health
זיבוקסיד 600 מג
pfizer pfe pharmaceuticals israel ltd - linezolid - טבליה - linezolid 600 mg - linezolid - linezolid - therapy is indicated only when an organism resistant to all other antibiotics is suspected. zyvoxid is indicated in adult and pediatric patients for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as: 1) pneumonia - community acquired and nosocomial pneumonia including multi drug resistant streptococcus pneumonia (mdrsp). 2) skin and soft tissue infections including diabetic foot infections. 3) enterococcal infections. combination therapy may be indicated if a concomitant gram negative pathogen is documented or suspected.